HomeNewsWorldUS lawmakers plan to split $908 billion COVID-19 plan into two parts: Source

US lawmakers plan to split $908 billion COVID-19 plan into two parts: Source

The plan’s highlights were made public on Dec. 1, but the authors now plan to divide them into two proposals that could be voted on separately, the source said.

December 14, 2020 / 07:47 IST
Story continues below Advertisement
Three pharma companies have applied for emergency use authorisation of their COVID-19 vaccines in India
Three pharma companies have applied for emergency use authorisation of their COVID-19 vaccines in India

A $908 billion bipartisan COVID-19 relief plan set to be introduced in the U.S. Congress as early as Monday will be split into two packages in a bid to win approval, a person briefed on the matter said.
The plan’s highlights were made public on Dec. 1, but the authors now plan to divide them into two proposals that could be voted on separately, the source said.

One will be a $748 billion measure, which contains money for small businesses, the jobless and COVID-19 vaccine distribution. The other will include some key sticking points: liability protections for business and $160 billion for state and local governments.

Story continues below Advertisement

The leaders of the House of Representatives and Senate did not immediately respond to requests for comment.

One of the sponsors of the $908 billion plan, Democratic Senator Joe Manchin, said earlier on Sunday it would be introduced formally on Monday.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show